Andrew Saul Artz, M.D., M.S.
Hematologist-Oncologist
4.9 (65 RATINGS)
Clinical Expertise
Stem cell transplantation
Leukemia
MDS
Anemia
Older Patients
Appointments
Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
Director, Aging and Blood Cancers Program
Deputy Director of Outcomes, Center for Cancer and Aging
Clinical Teams
Research Teams
I cherish the bonds formed with patients and their families.
Andrew Artz, M.D., M.S., has spent decades tending to the special needs of older people battling leukemia and blood diseases. An acknowledged leader in the field, he has created unique, multidisciplinary programs to put his senior patients in the best possible condition before they receive lifesaving stem cell transplants. He also has led research to better understand and treat anemia in older persons.
Dr. Artz received his medical degree in his home state at West Virginia University in Morgantown, West Virginia. Medicine residency was completed at Georgetown University in Washington, D.C., followed by hematology/oncology fellowship at the University of Chicago then six months of transplant training as a visiting physician at the Fred Hutchinson Cancer Center in Seattle. He was an attending hematologist and clinical director of the transplant program at the University of Chicago before moving to City of Hope.
At City of Hope, Dr. Artz directs the Aging and Blood Cancers Program. “When I first came to City of Hope,” he says, “I could feel the energy and optimism coursing through the blood of the institution, uniformly committed to eradicating cancer. I feel fortunate to be at City of Hope.”
Dr. Artz received his medical degree in his home state at West Virginia University in Morgantown, West Virginia. Medicine residency was completed at Georgetown University in Washington, D.C., followed by hematology/oncology fellowship at the University of Chicago then six months of transplant training as a visiting physician at the Fred Hutchinson Cancer Center in Seattle. He was an attending hematologist and clinical director of the transplant program at the University of Chicago before moving to City of Hope.
At City of Hope, Dr. Artz directs the Aging and Blood Cancers Program. “When I first came to City of Hope,” he says, “I could feel the energy and optimism coursing through the blood of the institution, uniformly committed to eradicating cancer. I feel fortunate to be at City of Hope.”
2005-Present, Medical Oncology, American Board of Internal Medicine
2005-Present, Hematology, American Board of Internal Medicine
2000-2010, Internal Medicine, American Board of Internal Medicine
2001-Present, Medical License, State of Illinois. License number 36103920
2002-2004, Masters of Science for Clinical Professionals, Department of Health Studies, University of Chicago, Chicago, Illinois
1993-1997, M.D., West Virginia University, Morgantown, West Virginia
1988-1992, B.A., Molecular Biology, University of Colorado, Boulder, Colorado
2001-2004, Fellowship in Hematology and Oncology, University of Chicago, Chicago, Illinois
1997-2000, Internal Medicine Residency, Georgetown University, Washington, DC
2021-present, Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California
2019-2021, Associate Clinical Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California
2014-2019, Associate Professor, Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois
2007-2013, Assistant Professor, Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois
2005-2007, Instructor, Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois
2012, Distinguished Leader In Program Innovation Award, University of Chicago BSD
2009, Best Clinical Research Abstract, Department of Medicine University of Chicago
2004, ASH Travel Grant
2004, ASBMT Travel Grant
2002, Fellow Teaching Award Nominee. University of Chicago
2002, Scholarship, University of Chicago Department of Health Studies
2000, Pearls nominee-medical student teaching award. Georgetown University
2000, Dudley P Jackson Award for Outstanding Resident Teaching. Georgetown University
2000, Hugh Hussey Teaching Award. Georgetown University
1997, Lange Book Award. West Virginia University School of Medicine
1997, Alpha Omega Alpha. West Virginia University School of Medicine
1993, Class President, West Virginia University School of Medicine
American Medical Association
ACP-ASIM
American Society of Clinical Oncology
American Society of Hematology
American Society for Blood and Marrow Transplantation
Ambrosy AP, Gurwitz JH, Tabada GH, Artz A, Schrier S, Rao SV, Barnhart HX, Reynolds K, Smith DH, Peterson PN, Sung SH, Cohen HJ, Go AS. Incident Anemia in Older Adults with Heart Failure Rate, Etiology, and Association with Outcomes. Eur Heart J Qual Care Clin Outcomes. 2019 Mar 7. PMID: 30847487.
Chen YB, Le-Rademacher J, Brazauskas R, Kiefer DM, Hamadani M, DiPersio JF,Litzow MR, Craig M, Horwitz ME, Artz AS, McClune BL, Fernandez HF, Duong HK, Kobusingye H, Proue M, Drexler RJ, Horowitz MM, Shaw BE, Miller JP, Hosoba S, Waller EK, Devine SM. Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells. Blood Adv. 2019 Mar 26;3(6):875-883. DOI: 10.1182/bloodadvances. PubMed PMID: 30890544.
Fan Y, Artz AS, van Besien K, Stock W, Larson RA, Odenike O, Godley LA, Kline J, Cunningham JM, LaBelle JL, Bishop MR, Liu H. Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant. Exp Hematol Oncol. 2019 Jan 3;8:1. PubMed PMID: 30622841; PubMed Central PMCID: PMC6317199.
Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors. Haematologica. 2018 Oct 31 PMID: 30381298.
Thakar M, Broglie L, Logan B, Artz A, Bunin N, Burroughs LM, Fretham C, Jacobsohn DA, Loren AW, Kurtzberg J, Martinez CA, Mineishi S, Nelson AS, Woolfrey A, Pasquini MC, Sorror ML. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for non-malignant diseases. Blood. 2018 Dec 13. PubMed PMID: 30545834.
Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant. 2018 Nov 10. pii: S1083-8791(18)30698-0. PubMed PMID: 30423480.
Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I,Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors. Haematologica. 2018 Oct 31. PMID: 30381298.
D'Angelo CR, Novitsky B, Mee Lee S, Godley LA, Kline J, Larson RA, Liu H,Odenike O, Stock W, Bishop MR, Artz AS. Characterization of cancer comorbidityprior to allogeneic hematopoietic cell transplantation. Leuk Lymphoma. 2018 Aug 2:1-10. PubMed PMID: 30070150.
Rosko AE, Olin RL, Artz A, Wildes TM, Stauder R, Klepin HD. A call to action in hematologic disorders: A report from the ASH scientific workshop on hematology and aging. J Geriatr Oncol. 2018 Jul;9(4):287-290. Epub 2018 May 16. PubMed PMID: 29759912.
Harris AC, Boelens JJ, Ahn KW, Fei M, Abraham A, Artz A, Dvorak C, Frangoul H, Freytes C, Gale RP, Hong S, Lazarus HM, Loren A, Mineishi S, Nishihori T, O'Brien T, Williams K, Pasquini MC, Levine JE. Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine. Blood Adv. 2018 Jun 12;2(11):1198-1206. PubMed PMID: 29844205; PubMed Central PMCID: PMC5998928.
Gooptu M, Kim HT, Chen YB, Rybka W, Artz A, Boyer M, Johnston L, McGuirk J, Shea TC, Jagasia M, Shaughnessy PJ, Reynolds CG, Fields M, Alyea EP, Ho VT, Glavin F, Dipersio JF, Westervelt P, Ritz J, Soiffer RJ. Effect of anti-human T-lymphocyte globulin (ATLG) on immune recovery following myeloablative allogeneic stem-cell transplantation with matched unrelated donors: Analysis of immune reconstitution in a double-blind randomized controlled trial. Biol Blood Marrow Transplant. 2018 Jul 10. pii: S1083-8791(18)30387-2. PubMed PMID: 30006305.
Strouse C, Zhang Y, Zhang MJ, DiGilio A, Pasquini M, Horowitz MM, Lee S, Ho V,Ramanathan M, Chinratanalab W, Loren A, Burns LJ, Artz A, Villa KF, Saber W. “Risk Score for Development of Veno-Occlusive Disease After Allogeneic Hematopoietic Cell Transplant". Biol Blood Marrow Transplant. 2018 Jun 18. pii: S1083-8791(18)30325-2. DOI: 10.1016/j.bbmt.2018.06.013. PubMed PMID: 29928989.
Wang AY, Weiner H, Green M, Chang H, Fulton N, Larson RA, Odenike O, Artz AS, Bishop MR, Godley LA, Thirman MJ, Kosuri S, Churpek JE, Curran E, Pettit K, Stock W, Liu H. A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. J Hematol Oncol. 2018 Jan 5;11(1):4. DOI: 10.1186/s13045-017-0550-8. PubMed PMID: 29304833; PubMed Central PMCID: PMC5756334.
Tsai SB, Rhodes J, Liu H, Shore T, Bishop M, Cushing MM, Gergis U, Godley L, Kline J, Larson RA, Mayer S, Odenike O, Stock W, Wickrema A, van Besien K, Artz AS. Reduced Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared to Matched Unrelated Donor Stem Cells in Older Adults. Biol Blood Marrow Transplant. 2017 Dec 27. pii: S1083-8791(17)31824-4. PubMed PMID: 29288821.
Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens JJ, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI. Acute Leukemia Committee of the CIBMTR. Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia. Biol Blood Marrow Transplant. 2017 Dec 25. pii: S1083-8791(17)30872-8. DOI: 10.1016/j.bbmt.2017.11.025. [Epub ahead of print] PubMed PMID: 29197676.
Hsu J, Artz A, Mayer SA, Guarner D, Bishop MR, Reich-Slotky R, Smith SM, Greenberg J, Kline J, Ferrante R, Phillips AA, Gergis U, Liu H, Stock W, Cushing M, Shore TB, van Besien K. Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia. Biol Blood Marrow Transplant. 2018 Feb;24(2):359-365.DOI: 10.1016/j.bbmt.2017.10.040. Epub 2017 Nov 8. PubMed PMID: 29128555.
Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, Rybka W, Artz A, Porter DL, Shea TC, Boyer MW, Maziarz RT, Shaughnessy PJ, Gergis U, Safah H, Reshef R, DiPersio JF, Stiff PJ, Vusirikala M, Szer J, Holter J, Levine JD, Martin PJ, Pidala JA, Lewis ID, Ho VT, Alyea EP, Ritz J, Glavin F, Westervelt P, Jagasia MH, Chen YB. Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. J Clin Oncol. 2017 Dec 20;35(36):4003-4011. DOI: 10.1200/JCO.2017.75.8177. Epub 2017 Oct 17. PubMed PMID: 29040031.
Chen LW, McShane PJ, Karkowsky W, Gray SE, Adegunsoye A, Stock W, Artz A, White SR, Montner SM, Strek ME. De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy. Chest. 2017 Sep;152(3):683-685. DOI: 10.1016/j.chest.2017.06.042. PMID: 28889888
Muffly L, Pasquini MC, Martens M, Brazauskas R, Zhu X, Adekola K, Aljurf M, Ballen KK, Bajel A, Baron F, Battiwalla M, Beitinjaneh A, Cahn JY, Carabasi M, Chen YB, Chhabra S, Ciurea S, Copelan E, D'Souza A, Edwards J, Foran J, Freytes CO, Fung HC, Gale RP, Giralt S, Hashmi SK, Hildebrandt GC, Ho V, Jakubowski A,Lazarus H, Luskin MR, Martino R, Maziarz R, McCarthy P, Nishihori T, Olin R,Olsson RF, Pawarode A, Peres E, Rezvani AR, Rizzieri D, Savani BN, Schouten HC, Sabloff M, Seftel M, Seo S, Sorror ML, Szer J, Wirk BM, Wood WA, Artz A. Increasing use of allogeneic hematopoietic cell transplantation in patients age 70 years and older in the United States. Blood. 2017 Jul 3. pii: blood-2017-03-772368. DOI: 10.1182/blood-2017-03-772368. [Epub ahead of print] PubMed PMID: 28674027.
Khan N, Hantel A, Knoebel RW, Artz A, Larson RA, Godley LA, Thirman MJ, Liu H, Churpek JE, King D, Odenike O, Stock W. Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia. Leuk Lymphoma. 2017 Feb 20:1-7. DOI: 10.1080/10428194.2017.1289524. [Epub ahead of print] PubMed PMID: 28278716.
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Ratings
5.0
Show respect for what you say
5.0
Provider explain in way you understand
5.0
Provider listen carefully to you
4.9
Rate provider 0-10
4.8
Know important info medical history
4.8
Spend enough time with you
4.8
Recommend this provider office
Reviews
01/29/23
Five stars for wonderful Dr. Artz - Verified patient
10/30/22
I recommended my cousin who had severe cancer, only around a month to live. Her and her family were very pleased what Dr. Artz had to say ,plus he listened to their concerns. My cousin passed away she requested that all gifts, flowers and donations are not needed, but donate the money to City of Hope on her behalf. - Verified patient
10/06/22
Dr. Artz and his staff are # 1 in client care and COH is # 1 in finding cures for cancer. We patients appreciate your dedication and care for you patients. - Verified patient
09/22/22
My husband was with me at this appointment and I appreciated the provider including him in the conversation. - Verified patient
03/30/22
Dr. Artz is a good listener. His SENIOR cancer patient "care" program is a GREAT idea! - Verified patient